As of this week, Triall will introduce all of its team members on a weekly basis, starting with our CEO and co-founder Hadil Es-Sbai!
Hadil majored in analytical chemistry at the VU University Amsterdam, the Netherlands. He has a background of 20+ years in clinical development and assumed several roles within the pharmaceutical and clinical contract research industries. Hadil has acquired extensive experience managing international clinical trials (phase I-IV) within a wide range of therapeutic areas. He became an entrepreneur in 2006 and has since combined several functions that are all related to business development and innovation in the pharmaceutical and clinical domain. Hadil co-founded several service-driven pharmaceutical companies, including the contract research service providers Herakles Life Sciences Group in 2007 and CR2O in 2008, acting as executive managing director and CEO to date, respectively. His colleagues see him as an empathetic and tireless leader, who gears all his entrepreneurial initiatives towards making innovative treatments accessible to those in need.
Fun fact: Hadil enjoys challenging his colleagues’ dietary plans by bringing cake to the office for the smallest occasions 🍰
Hadil on his involvement in Triall: ‘’The covid-19 pandemic seems to have changed our lives forever. Where clinical trials initially faced major disruption, we now see emerging technologies like telemedicine, Electronic Health Records, decentralized/virtual trials, and digital therapeutics being embraced at record speed. We believe that the Triall ecosystem will bring all these innovations together for the benefit of faster, smarter and cost-effective clinical operations.‘’
Hadil’s entrepreneurial drive, positive spirit, and deep knowledge of the industry are invaluable to materializing our vision. We are very happy to have Hadil as a part of our team!